IBRX ALERT Hagens Berman National Trial Attorneys Encourages ImmunityBio IBRX Investors with Substantial Losses to Contact Firms Attorneys Securities Fraud Class Action Filed

SAN FRANCISCO, July 02, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022 – May 10, 2023 Lead Plaintiff Deadline: Aug. 29, 2023 Visit: www.hbsslaw.com/investor-fraud/IBRX Contact An Attorney Now: IBRX@hbsslaw.com 844-916-0895 ImmunityBio, Inc.…Read More